Patent Law Updates

Featured Expert Legal Commentary

Int’l Seaway Trading v. Walgreens: The Ordinary Observer Test Is the Sole Test of Invalidity of a Design Patent

By Olivier A. Taillieu and Thomas F. Zuber of Zuber & Taillieu LLP

The U.S. Court of Appeals for the Federal Circuit has extended the holding of Egyptian Goddess v. Swisa, 435 F.3d 665 (Fed. Cir. 2008), and held that the “point of novelty” test should no longer be applied to determine validity of a design patent. In Int’l Seaway Trading Corp. v.… More...

More Patent Law Updates

Sort by:
Page 2 of 3 of Patent Law Commentaries
 <  1 2 3 >

Recent Decisions Alter Venue Strategy In Eastern District of Texas Patent Litigation

In re Volkswagen of America Inc./In re TS Tech USA Corp.  |  March 24, 2009

In the wake of two recent federal appeals cases -- In re Volkswagen of America Inc., 545 F.3d 304 (5th Cir. 2008) and In re TS Tech USA Corp., 551 F.3d 1315 (Fed. Cir. 2008) – the Eastern District of Texas has lost some of its steam as the most notable “rocket docket” of patent infringement More...

Egyptian Goddess v. Swisa: No more Point of Novelty Test for Design Patent Infringement

Egyptian Goddess v. Swisa  |  January 13, 2009

In its highly anticipated en banc opinion in Egyptian Goddess v. Swisa, 543 F.3d 665 (Fed. Cir. 2008), the Court of Appeals for the Federal Circuit rejected the point of novelty test for design patent infringement. The Court held that the “ordinary observer” test set forth in Gorham v. White is More...

In re Bilski: Business Method Patents Take a Hit; State Street Bank Is Out

In re Bilski  |  January 7, 2009

The eagerly-awaited decision in In re Bilski, 545 F.3d 943 (Fed. Cir. 2008) -- issued by the U.S. Court of Appeals for the Federal Circuit sitting en banc -- significantly narrowed the scope of patentability for business method and process patents. The Court essentially discounted the More...

Cohesive Technologies v. Waters: Anticipated Though Non-Obvious?

December 11, 2008

In Cohesive Technologies, Inc. v. Waters Corporation, 543 F.3d 1351 (Fed. Cir. 2008), the U.S. Court of Appeals for the Federal Circuit held that an invention may be anticipated, even though it is proven non-obvious. The Court drew a clear separating line between the novelty analysis of 35 U.S.C. More...

Quanta Computer v. LG Electronics: Reviving Exhaustion, Applying It to Method Patents

Quanta Computer v. LG Electronics  |  August 15, 2008

In the case Quanta Computer v. LG Electronics, ___ U.S. ____, 128 S.Ct. 2109 (2008), the United States Supreme Court clarifies and expands upon its holding in United States v. Univis Lens Co. In Univis, the court held that a patent is exhausted upon the sale of unfinished components that More...

Acumed II Addresses the Issue of Claim Preclusion and When a Patent Claim Could Have Been Brought

Acumed, LLC v. Stryker Corp., et al.  |  May 20, 2008

In the recent case of Acumed, LLC v. Stryker Corp.,et al., (No. 2007-1115) (Fed. Cir., May 13, 2008) (“Acumed II”), the Federal Circuit addressed the meaning and application of language barring re-litigation of claims that “could have been brought” in a prior patent infringement case. More...

Agrizap and Ortho-McNeil: Two Sides of Post-KSR Obviousness

Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc., et al.  |  May 16, 2008

In KSR v. Teleflex, 550 U.S. ____, 127 S. Ct. 1727 (2007), the U.S. Supreme Court broadened the applicable test in determining whether an invention is “obvious.” As predicted by patent law pundits, the KSR decision was followed by a number of cases in which infringers defended their actions – More...

Judkins v. HT Window Fashion: Can’t Stop a Patent Holder from Contacting Your Clients About Possible Infringement

Judkins v. HT Window Fashion Corp.  |  May 13, 2008

When a patent-holder discovers infringement, it’s not unreasonable for him to want to notify the alleged infringer’s clients of the infringement. Of course the alleged infringer would prefer that this communication with its clients not take place. But, as the Judkins case instructs, it will be More...

Tafas v. Dudas: USPTO’s Efforts to Limit Patent Applicant Rights Are Void

Tafas v. Dudas, et al.  |  May 12, 2008

In an effort to attack its notorious backlog, the USPTO enacted a group of rule changes that placed limits on, among other things, the number of claims a patent applicant could include and the number of times an applicant could amend and continue his application. Traditionally, patent applicants More...

McKesson v. Bridge Medical: Inequitable Conduct Due to Lack of Full Disclosure in Patent Prosecutions

McKesson Information Solutions, Inc. v. Bridge Medical, Inc.  |  January 18, 2008

The decision in McKesson Information Solutions Inc. v. Bridge Medical Inc., 487 F.3d 897 (Fed. Cir. 2007), has been referred to by many as “frightening,” “burdensome,” and “a whopper.” Indeed, the decision places a high burden on patent prosecutors to disclose essentially every action More...

Page 2 of 3 of Patent Law Commentaries
 <  1 2 3 >
Advertise with LawUpdates.com

Companies Mentioned

Patent Law

The following companies are mentioned in Patent Law Updates:

Wal-Mart Stores, Inc.

Boston Scientific Scimed, Inc.

Hana Microelectronics Co., Ltd.

Boston Scientific Corp.

CVS Corp.

Target Corp.

Daiwa Products, Inc.

Sears Holding Corp.

S.A.A.T. Systems Application of Advanced Technology, Ltd.

Motherswear International, Redcats USA, L.P. d.b.a. Lane Bryant Catalog

Prometheus Laboratories, Inc.

Leading Lady, Macy’s Department, Inc.

Mayo Collaborative Services d.b.a. Mayo Medical Laboratories

Kohl’s Department Stores, Inc.

Mayo Clinic Rochester

K-Mart Corp.

Shanghai Honest Tool Co., Inc.

J.C. Penney Company, Inc.

Forest Group, Inc.

Glamourmom LLC

McKesson Information Solutions, Inc.

Cibon Industrial

Federated Department Stores

Bridge Medical, Inc.

Bon Tool Company

Elizabeth Lange LLC d.b.a. Liz Lange Maternity

United States Patent and Trademark Office

Walgreens Corp.

U.S. Patent and Trademark Office

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, plc.)

Touchsport Footwear USA, Inc.

SmithKline Beecham PLC

HT Window Fashion Corp.

International Seaway Trading Corp.

SmithKline Beecham Corp. d.b.a GlaxoSmithKline

Glaxo Group Limited d.b.a. GlaxoSmithKline

Ortho-McNeil Pharmaceutical, Inc.

Ranbaxy, Inc.

Mylan Pharmaceutical, Inc.

Teva Pharmaceuticals USA, Inc.

Mylan Laboratories, Inc.

Abbott Laboratories

Stryker Sales Corp.

Sandoz, Inc.

Stryker Orthopaedics

Sandoz GMBH

Stryker Corp.

Astellas Pharma, Inc.

Howmedica Osteonics Corp.

Teva Pharmaceuticals Industries, Ltd.

Additional Resources

Patent Law